nodes	percent_of_prediction	percent_of_DWPC	metapath
Vilazodone—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.0586	0.0809	CbGbCtD
Vilazodone—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.0551	0.0761	CbGbCtD
Vilazodone—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.0551	0.0761	CbGbCtD
Vilazodone—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.0498	0.0688	CbGbCtD
Vilazodone—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.0498	0.0688	CbGbCtD
Vilazodone—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.043	0.0594	CbGbCtD
Vilazodone—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.0418	0.0577	CbGbCtD
Vilazodone—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.0378	0.0522	CbGbCtD
Vilazodone—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.0378	0.0522	CbGbCtD
Vilazodone—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0373	0.0515	CbGbCtD
Vilazodone—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.035	0.0484	CbGbCtD
Vilazodone—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.035	0.0484	CbGbCtD
Vilazodone—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.0317	0.0438	CbGbCtD
Vilazodone—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.0317	0.0438	CbGbCtD
Vilazodone—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.0274	0.0378	CbGbCtD
Vilazodone—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.0266	0.0367	CbGbCtD
Vilazodone—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.024	0.0332	CbGbCtD
Vilazodone—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.024	0.0332	CbGbCtD
Vilazodone—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.023	0.0318	CbGbCtD
Vilazodone—DRD2—nerve—acquired immunodeficiency syndrome	0.00249	0.0934	CbGeAlD
Vilazodone—SLC6A4—blood plasma—acquired immunodeficiency syndrome	0.00235	0.0881	CbGeAlD
Vilazodone—HTR1A—blood plasma—acquired immunodeficiency syndrome	0.00209	0.0782	CbGeAlD
Vilazodone—CYP2C18—digestive system—acquired immunodeficiency syndrome	0.00176	0.066	CbGeAlD
Vilazodone—CYP2C18—vagina—acquired immunodeficiency syndrome	0.00155	0.0583	CbGeAlD
Vilazodone—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.00115	0.0431	CbGeAlD
Vilazodone—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.00113	0.0425	CbGeAlD
Vilazodone—DRD2—retina—acquired immunodeficiency syndrome	0.00103	0.0387	CbGeAlD
Vilazodone—SLC6A4—digestive system—acquired immunodeficiency syndrome	0.000903	0.0339	CbGeAlD
Vilazodone—SLC6A4—blood—acquired immunodeficiency syndrome	0.00086	0.0323	CbGeAlD
Vilazodone—SLC6A4—spinal cord—acquired immunodeficiency syndrome	0.000829	0.0311	CbGeAlD
Vilazodone—SLC6A4—lung—acquired immunodeficiency syndrome	0.000754	0.0283	CbGeAlD
Vilazodone—HTR1A—spinal cord—acquired immunodeficiency syndrome	0.000736	0.0276	CbGeAlD
Vilazodone—SLC6A4—nervous system—acquired immunodeficiency syndrome	0.000698	0.0262	CbGeAlD
Vilazodone—SLC6A4—central nervous system—acquired immunodeficiency syndrome	0.000672	0.0252	CbGeAlD
Vilazodone—HTR1A—nervous system—acquired immunodeficiency syndrome	0.00062	0.0233	CbGeAlD
Vilazodone—Nervousness—Indinavir—acquired immunodeficiency syndrome	0.000615	0.00247	CcSEcCtD
Vilazodone—Skin disorder—Abacavir—acquired immunodeficiency syndrome	0.000612	0.00246	CcSEcCtD
Vilazodone—DRD2—lung—acquired immunodeficiency syndrome	0.000605	0.0227	CbGeAlD
Vilazodone—Hallucination—Ritonavir—acquired immunodeficiency syndrome	0.000605	0.00243	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Nevirapine—acquired immunodeficiency syndrome	0.000603	0.00242	CcSEcCtD
Vilazodone—Malnutrition—Efavirenz—acquired immunodeficiency syndrome	0.000598	0.0024	CcSEcCtD
Vilazodone—Connective tissue disorder—Ritonavir—acquired immunodeficiency syndrome	0.000597	0.0024	CcSEcCtD
Vilazodone—HTR1A—central nervous system—acquired immunodeficiency syndrome	0.000597	0.0224	CbGeAlD
Vilazodone—Vision blurred—Indinavir—acquired immunodeficiency syndrome	0.000597	0.0024	CcSEcCtD
Vilazodone—Paraesthesia—Nevirapine—acquired immunodeficiency syndrome	0.000594	0.00239	CcSEcCtD
Vilazodone—Tremor—Indinavir—acquired immunodeficiency syndrome	0.000593	0.00238	CcSEcCtD
Vilazodone—Convulsion—Zidovudine—acquired immunodeficiency syndrome	0.00059	0.00237	CcSEcCtD
Vilazodone—Flatulence—Efavirenz—acquired immunodeficiency syndrome	0.000589	0.00237	CcSEcCtD
Vilazodone—Somnolence—Nevirapine—acquired immunodeficiency syndrome	0.000588	0.00236	CcSEcCtD
Vilazodone—Dysgeusia—Efavirenz—acquired immunodeficiency syndrome	0.000586	0.00235	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Nelfinavir—acquired immunodeficiency syndrome	0.000584	0.00235	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Stavudine—acquired immunodeficiency syndrome	0.000582	0.00234	CcSEcCtD
Vilazodone—Hallucination—Saquinavir—acquired immunodeficiency syndrome	0.000582	0.00234	CcSEcCtD
Vilazodone—Agitation—Indinavir—acquired immunodeficiency syndrome	0.000582	0.00234	CcSEcCtD
Vilazodone—Nervousness—Efavirenz—acquired immunodeficiency syndrome	0.000581	0.00233	CcSEcCtD
Vilazodone—Insomnia—Nelfinavir—acquired immunodeficiency syndrome	0.00058	0.00233	CcSEcCtD
Vilazodone—Arthralgia—Zidovudine—acquired immunodeficiency syndrome	0.000579	0.00233	CcSEcCtD
Vilazodone—Asthenia—Amprenavir—acquired immunodeficiency syndrome	0.000579	0.00233	CcSEcCtD
Vilazodone—Insomnia—Stavudine—acquired immunodeficiency syndrome	0.000578	0.00232	CcSEcCtD
Vilazodone—Paraesthesia—Nelfinavir—acquired immunodeficiency syndrome	0.000576	0.00231	CcSEcCtD
Vilazodone—Unspecified disorder of skin and subcutaneous tissue—Zidovudine—acquired immunodeficiency syndrome	0.000575	0.00231	CcSEcCtD
Vilazodone—Decreased appetite—Nevirapine—acquired immunodeficiency syndrome	0.000575	0.00231	CcSEcCtD
Vilazodone—Connective tissue disorder—Saquinavir—acquired immunodeficiency syndrome	0.000575	0.00231	CcSEcCtD
Vilazodone—Paraesthesia—Stavudine—acquired immunodeficiency syndrome	0.000574	0.0023	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Abacavir—acquired immunodeficiency syndrome	0.000574	0.0023	CcSEcCtD
Vilazodone—Malnutrition—Delavirdine—acquired immunodeficiency syndrome	0.000572	0.0023	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Nevirapine—acquired immunodeficiency syndrome	0.000571	0.0023	CcSEcCtD
Vilazodone—Fatigue—Nevirapine—acquired immunodeficiency syndrome	0.000571	0.00229	CcSEcCtD
Vilazodone—Somnolence—Nelfinavir—acquired immunodeficiency syndrome	0.00057	0.00229	CcSEcCtD
Vilazodone—Insomnia—Abacavir—acquired immunodeficiency syndrome	0.000569	0.00229	CcSEcCtD
Vilazodone—Somnolence—Stavudine—acquired immunodeficiency syndrome	0.000568	0.00228	CcSEcCtD
Vilazodone—Eye disorder—Ritonavir—acquired immunodeficiency syndrome	0.000568	0.00228	CcSEcCtD
Vilazodone—Paraesthesia—Abacavir—acquired immunodeficiency syndrome	0.000565	0.00227	CcSEcCtD
Vilazodone—Dyspepsia—Nelfinavir—acquired immunodeficiency syndrome	0.000564	0.00227	CcSEcCtD
Vilazodone—Cardiac disorder—Ritonavir—acquired immunodeficiency syndrome	0.000564	0.00227	CcSEcCtD
Vilazodone—Flatulence—Delavirdine—acquired immunodeficiency syndrome	0.000564	0.00226	CcSEcCtD
Vilazodone—Vision blurred—Efavirenz—acquired immunodeficiency syndrome	0.000564	0.00226	CcSEcCtD
Vilazodone—Dyspepsia—Stavudine—acquired immunodeficiency syndrome	0.000563	0.00226	CcSEcCtD
Vilazodone—DRD2—nervous system—acquired immunodeficiency syndrome	0.00056	0.021	CbGeAlD
Vilazodone—Dysgeusia—Delavirdine—acquired immunodeficiency syndrome	0.00056	0.00225	CcSEcCtD
Vilazodone—Tremor—Efavirenz—acquired immunodeficiency syndrome	0.00056	0.00225	CcSEcCtD
Vilazodone—Palpitations—Indinavir—acquired immunodeficiency syndrome	0.000559	0.00225	CcSEcCtD
Vilazodone—Decreased appetite—Nelfinavir—acquired immunodeficiency syndrome	0.000557	0.00224	CcSEcCtD
Vilazodone—Nervousness—Delavirdine—acquired immunodeficiency syndrome	0.000556	0.00223	CcSEcCtD
Vilazodone—Decreased appetite—Stavudine—acquired immunodeficiency syndrome	0.000556	0.00223	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Nelfinavir—acquired immunodeficiency syndrome	0.000553	0.00222	CcSEcCtD
Vilazodone—Diarrhoea—Amprenavir—acquired immunodeficiency syndrome	0.000552	0.00222	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Stavudine—acquired immunodeficiency syndrome	0.000552	0.00222	CcSEcCtD
Vilazodone—Fatigue—Stavudine—acquired immunodeficiency syndrome	0.000551	0.00221	CcSEcCtD
Vilazodone—Agitation—Efavirenz—acquired immunodeficiency syndrome	0.00055	0.00221	CcSEcCtD
Vilazodone—Connective tissue disorder—Lamivudine—acquired immunodeficiency syndrome	0.000548	0.0022	CcSEcCtD
Vilazodone—Decreased appetite—Abacavir—acquired immunodeficiency syndrome	0.000547	0.0022	CcSEcCtD
Vilazodone—Eye disorder—Saquinavir—acquired immunodeficiency syndrome	0.000547	0.0022	CcSEcCtD
Vilazodone—Feeling abnormal—Nevirapine—acquired immunodeficiency syndrome	0.000545	0.00219	CcSEcCtD
Vilazodone—Nervous system disorder—Zidovudine—acquired immunodeficiency syndrome	0.000545	0.00219	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Abacavir—acquired immunodeficiency syndrome	0.000544	0.00218	CcSEcCtD
Vilazodone—Cardiac disorder—Saquinavir—acquired immunodeficiency syndrome	0.000543	0.00218	CcSEcCtD
Vilazodone—Fatigue—Abacavir—acquired immunodeficiency syndrome	0.000543	0.00218	CcSEcCtD
Vilazodone—Skin disorder—Zidovudine—acquired immunodeficiency syndrome	0.00054	0.00217	CcSEcCtD
Vilazodone—DRD2—central nervous system—acquired immunodeficiency syndrome	0.00054	0.0202	CbGeAlD
Vilazodone—Vision blurred—Delavirdine—acquired immunodeficiency syndrome	0.000539	0.00217	CcSEcCtD
Vilazodone—Arthralgia—Indinavir—acquired immunodeficiency syndrome	0.000539	0.00216	CcSEcCtD
Vilazodone—Hyperhidrosis—Zidovudine—acquired immunodeficiency syndrome	0.000537	0.00216	CcSEcCtD
Vilazodone—Tremor—Delavirdine—acquired immunodeficiency syndrome	0.000536	0.00215	CcSEcCtD
Vilazodone—Unspecified disorder of skin and subcutaneous tissue—Indinavir—acquired immunodeficiency syndrome	0.000535	0.00215	CcSEcCtD
Vilazodone—SLC6A4—brain—acquired immunodeficiency syndrome	0.000534	0.02	CbGeAlD
Vilazodone—Mental disorder—Ritonavir—acquired immunodeficiency syndrome	0.000533	0.00214	CcSEcCtD
Vilazodone—Malnutrition—Ritonavir—acquired immunodeficiency syndrome	0.000529	0.00213	CcSEcCtD
Vilazodone—Palpitations—Efavirenz—acquired immunodeficiency syndrome	0.000528	0.00212	CcSEcCtD
Vilazodone—Feeling abnormal—Nelfinavir—acquired immunodeficiency syndrome	0.000528	0.00212	CcSEcCtD
Vilazodone—Asthenia—Didanosine—acquired immunodeficiency syndrome	0.000528	0.00212	CcSEcCtD
Vilazodone—Dry mouth—Indinavir—acquired immunodeficiency syndrome	0.000527	0.00212	CcSEcCtD
Vilazodone—Agitation—Delavirdine—acquired immunodeficiency syndrome	0.000526	0.00211	CcSEcCtD
Vilazodone—Flatulence—Ritonavir—acquired immunodeficiency syndrome	0.000521	0.00209	CcSEcCtD
Vilazodone—Feeling abnormal—Abacavir—acquired immunodeficiency syndrome	0.000519	0.00208	CcSEcCtD
Vilazodone—Dysgeusia—Ritonavir—acquired immunodeficiency syndrome	0.000518	0.00208	CcSEcCtD
Vilazodone—Convulsion—Efavirenz—acquired immunodeficiency syndrome	0.000518	0.00208	CcSEcCtD
Vilazodone—Nervousness—Ritonavir—acquired immunodeficiency syndrome	0.000514	0.00206	CcSEcCtD
Vilazodone—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.000513	0.00206	CcSEcCtD
Vilazodone—Mental disorder—Saquinavir—acquired immunodeficiency syndrome	0.000513	0.00206	CcSEcCtD
Vilazodone—Malnutrition—Saquinavir—acquired immunodeficiency syndrome	0.000509	0.00205	CcSEcCtD
Vilazodone—Arthralgia—Efavirenz—acquired immunodeficiency syndrome	0.000509	0.00204	CcSEcCtD
Vilazodone—Nervous system disorder—Indinavir—acquired immunodeficiency syndrome	0.000507	0.00203	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Zidovudine—acquired immunodeficiency syndrome	0.000506	0.00203	CcSEcCtD
Vilazodone—Palpitations—Delavirdine—acquired immunodeficiency syndrome	0.000506	0.00203	CcSEcCtD
Vilazodone—Unspecified disorder of skin and subcutaneous tissue—Efavirenz—acquired immunodeficiency syndrome	0.000506	0.00203	CcSEcCtD
Vilazodone—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.000504	0.00202	CcSEcCtD
Vilazodone—Insomnia—Zidovudine—acquired immunodeficiency syndrome	0.000502	0.00202	CcSEcCtD
Vilazodone—Flatulence—Saquinavir—acquired immunodeficiency syndrome	0.000502	0.00202	CcSEcCtD
Vilazodone—Skin disorder—Indinavir—acquired immunodeficiency syndrome	0.000502	0.00202	CcSEcCtD
Vilazodone—Hyperhidrosis—Indinavir—acquired immunodeficiency syndrome	0.000499	0.00201	CcSEcCtD
Vilazodone—Paraesthesia—Zidovudine—acquired immunodeficiency syndrome	0.000499	0.002	CcSEcCtD
Vilazodone—Dysgeusia—Saquinavir—acquired immunodeficiency syndrome	0.000499	0.002	CcSEcCtD
Vilazodone—Vision blurred—Ritonavir—acquired immunodeficiency syndrome	0.000499	0.002	CcSEcCtD
Vilazodone—Dry mouth—Efavirenz—acquired immunodeficiency syndrome	0.000498	0.002	CcSEcCtD
Vilazodone—Tremor—Ritonavir—acquired immunodeficiency syndrome	0.000496	0.00199	CcSEcCtD
Vilazodone—Somnolence—Zidovudine—acquired immunodeficiency syndrome	0.000494	0.00198	CcSEcCtD
Vilazodone—Dyspepsia—Zidovudine—acquired immunodeficiency syndrome	0.000489	0.00196	CcSEcCtD
Vilazodone—Arthralgia—Delavirdine—acquired immunodeficiency syndrome	0.000487	0.00196	CcSEcCtD
Vilazodone—Agitation—Ritonavir—acquired immunodeficiency syndrome	0.000486	0.00195	CcSEcCtD
Vilazodone—Malnutrition—Lamivudine—acquired immunodeficiency syndrome	0.000486	0.00195	CcSEcCtD
Vilazodone—Decreased appetite—Zidovudine—acquired immunodeficiency syndrome	0.000483	0.00194	CcSEcCtD
Vilazodone—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.00048	0.00193	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.00048	0.00193	CcSEcCtD
Vilazodone—Fatigue—Zidovudine—acquired immunodeficiency syndrome	0.000479	0.00192	CcSEcCtD
Vilazodone—Flatulence—Lamivudine—acquired immunodeficiency syndrome	0.000479	0.00192	CcSEcCtD
Vilazodone—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	0.000479	0.00192	CcSEcCtD
Vilazodone—Tremor—Saquinavir—acquired immunodeficiency syndrome	0.000477	0.00192	CcSEcCtD
Vilazodone—Dry mouth—Delavirdine—acquired immunodeficiency syndrome	0.000476	0.00191	CcSEcCtD
Vilazodone—Dysgeusia—Lamivudine—acquired immunodeficiency syndrome	0.000476	0.00191	CcSEcCtD
Vilazodone—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000475	0.00191	CcSEcCtD
Vilazodone—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	0.000474	0.0019	CcSEcCtD
Vilazodone—HTR1A—brain—acquired immunodeficiency syndrome	0.000474	0.0178	CbGeAlD
Vilazodone—Nervousness—Lamivudine—acquired immunodeficiency syndrome	0.000472	0.0019	CcSEcCtD
Vilazodone—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.000472	0.0019	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.000471	0.00189	CcSEcCtD
Vilazodone—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000468	0.00188	CcSEcCtD
Vilazodone—Agitation—Saquinavir—acquired immunodeficiency syndrome	0.000468	0.00188	CcSEcCtD
Vilazodone—Palpitations—Ritonavir—acquired immunodeficiency syndrome	0.000468	0.00188	CcSEcCtD
Vilazodone—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.000467	0.00188	CcSEcCtD
Vilazodone—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.000464	0.00186	CcSEcCtD
Vilazodone—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.00046	0.00185	CcSEcCtD
Vilazodone—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000459	0.00184	CcSEcCtD
Vilazodone—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000459	0.00184	CcSEcCtD
Vilazodone—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.000458	0.00184	CcSEcCtD
Vilazodone—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000458	0.00184	CcSEcCtD
Vilazodone—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.000455	0.00183	CcSEcCtD
Vilazodone—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000455	0.00183	CcSEcCtD
Vilazodone—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.000454	0.00182	CcSEcCtD
Vilazodone—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000453	0.00182	CcSEcCtD
Vilazodone—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000452	0.00181	CcSEcCtD
Vilazodone—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000451	0.00181	CcSEcCtD
Vilazodone—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.00045	0.00181	CcSEcCtD
Vilazodone—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000449	0.0018	CcSEcCtD
Vilazodone—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000447	0.0018	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000446	0.00179	CcSEcCtD
Vilazodone—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000445	0.00179	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000445	0.00179	CcSEcCtD
Vilazodone—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000442	0.0166	CbGeAlD
Vilazodone—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000441	0.00177	CcSEcCtD
Vilazodone—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000441	0.00177	CcSEcCtD
Vilazodone—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000441	0.00177	CcSEcCtD
Vilazodone—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000439	0.00176	CcSEcCtD
Vilazodone—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000438	0.00176	CcSEcCtD
Vilazodone—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000437	0.00176	CcSEcCtD
Vilazodone—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000437	0.00176	CcSEcCtD
Vilazodone—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.000435	0.0163	CbGeAlD
Vilazodone—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000434	0.00174	CcSEcCtD
Vilazodone—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000434	0.00174	CcSEcCtD
Vilazodone—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000431	0.00173	CcSEcCtD
Vilazodone—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000431	0.00173	CcSEcCtD
Vilazodone—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.00043	0.00173	CcSEcCtD
Vilazodone—DRD2—brain—acquired immunodeficiency syndrome	0.000428	0.0161	CbGeAlD
Vilazodone—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000426	0.00171	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000425	0.00171	CcSEcCtD
Vilazodone—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000424	0.0017	CcSEcCtD
Vilazodone—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000424	0.0017	CcSEcCtD
Vilazodone—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000424	0.0017	CcSEcCtD
Vilazodone—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000423	0.0017	CcSEcCtD
Vilazodone—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000423	0.0017	CcSEcCtD
Vilazodone—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000422	0.0017	CcSEcCtD
Vilazodone—CYP3A4—blood—acquired immunodeficiency syndrome	0.000421	0.0158	CbGeAlD
Vilazodone—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000421	0.00169	CcSEcCtD
Vilazodone—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000421	0.00169	CcSEcCtD
Vilazodone—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000421	0.00169	CcSEcCtD
Vilazodone—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000421	0.00169	CcSEcCtD
Vilazodone—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000419	0.00168	CcSEcCtD
Vilazodone—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000419	0.00168	CcSEcCtD
Vilazodone—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000417	0.00168	CcSEcCtD
Vilazodone—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000416	0.00167	CcSEcCtD
Vilazodone—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000415	0.00167	CcSEcCtD
Vilazodone—CYP2D6—blood—acquired immunodeficiency syndrome	0.000415	0.0156	CbGeAlD
Vilazodone—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000414	0.00166	CcSEcCtD
Vilazodone—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000411	0.00165	CcSEcCtD
Vilazodone—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000411	0.00165	CcSEcCtD
Vilazodone—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000408	0.00164	CcSEcCtD
Vilazodone—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000408	0.00164	CcSEcCtD
Vilazodone—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000406	0.00163	CcSEcCtD
Vilazodone—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000406	0.00163	CcSEcCtD
Vilazodone—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000405	0.00162	CcSEcCtD
Vilazodone—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000404	0.00162	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000403	0.00162	CcSEcCtD
Vilazodone—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000403	0.00162	CcSEcCtD
Vilazodone—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000402	0.00162	CcSEcCtD
Vilazodone—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000402	0.00161	CcSEcCtD
Vilazodone—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.0004	0.00161	CcSEcCtD
Vilazodone—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000399	0.0016	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000393	0.00158	CcSEcCtD
Vilazodone—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000393	0.00158	CcSEcCtD
Vilazodone—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000391	0.00157	CcSEcCtD
Vilazodone—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000389	0.00156	CcSEcCtD
Vilazodone—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000388	0.00156	CcSEcCtD
Vilazodone—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000385	0.00155	CcSEcCtD
Vilazodone—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000385	0.00155	CcSEcCtD
Vilazodone—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000384	0.00154	CcSEcCtD
Vilazodone—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000383	0.00154	CcSEcCtD
Vilazodone—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000381	0.00153	CcSEcCtD
Vilazodone—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.00038	0.00153	CcSEcCtD
Vilazodone—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.00038	0.00153	CcSEcCtD
Vilazodone—Nausea—Stavudine—acquired immunodeficiency syndrome	0.00038	0.00152	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000379	0.00152	CcSEcCtD
Vilazodone—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000376	0.00151	CcSEcCtD
Vilazodone—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000375	0.00151	CcSEcCtD
Vilazodone—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000374	0.0015	CcSEcCtD
Vilazodone—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000373	0.0015	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000373	0.0015	CcSEcCtD
Vilazodone—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000372	0.0015	CcSEcCtD
Vilazodone—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000371	0.00149	CcSEcCtD
Vilazodone—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.00037	0.00148	CcSEcCtD
Vilazodone—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000367	0.00148	CcSEcCtD
Vilazodone—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000366	0.00147	CcSEcCtD
Vilazodone—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000361	0.00145	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000361	0.00145	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000359	0.00144	CcSEcCtD
Vilazodone—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000359	0.00144	CcSEcCtD
Vilazodone—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000358	0.00144	CcSEcCtD
Vilazodone—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000356	0.00143	CcSEcCtD
Vilazodone—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000356	0.00143	CcSEcCtD
Vilazodone—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000353	0.00142	CcSEcCtD
Vilazodone—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000353	0.00142	CcSEcCtD
Vilazodone—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000353	0.00142	CcSEcCtD
Vilazodone—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.00035	0.00141	CcSEcCtD
Vilazodone—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000349	0.0014	CcSEcCtD
Vilazodone—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000345	0.00138	CcSEcCtD
Vilazodone—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000343	0.00138	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000342	0.00137	CcSEcCtD
Vilazodone—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000342	0.0128	CbGeAlD
Vilazodone—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000342	0.00137	CcSEcCtD
Vilazodone—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000342	0.00137	CcSEcCtD
Vilazodone—CYP2D6—nervous system—acquired immunodeficiency syndrome	0.000337	0.0126	CbGeAlD
Vilazodone—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000335	0.00135	CcSEcCtD
Vilazodone—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000334	0.00134	CcSEcCtD
Vilazodone—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.00033	0.00133	CcSEcCtD
Vilazodone—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000329	0.0124	CbGeAlD
Vilazodone—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000328	0.00132	CcSEcCtD
Vilazodone—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000327	0.00131	CcSEcCtD
Vilazodone—CYP2D6—central nervous system—acquired immunodeficiency syndrome	0.000324	0.0122	CbGeAlD
Vilazodone—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000323	0.0013	CcSEcCtD
Vilazodone—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.00032	0.00128	CcSEcCtD
Vilazodone—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.00031	0.00125	CcSEcCtD
Vilazodone—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.00031	0.00124	CcSEcCtD
Vilazodone—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000309	0.00124	CcSEcCtD
Vilazodone—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000307	0.00123	CcSEcCtD
Vilazodone—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000298	0.0012	CcSEcCtD
Vilazodone—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000297	0.00119	CcSEcCtD
Vilazodone—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000295	0.00119	CcSEcCtD
Vilazodone—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.00029	0.00116	CcSEcCtD
Vilazodone—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000286	0.00115	CcSEcCtD
Vilazodone—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000284	0.00114	CcSEcCtD
Vilazodone—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000284	0.00114	CcSEcCtD
Vilazodone—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000277	0.00111	CcSEcCtD
Vilazodone—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000275	0.0011	CcSEcCtD
Vilazodone—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000275	0.0011	CcSEcCtD
Vilazodone—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000271	0.00109	CcSEcCtD
Vilazodone—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000264	0.00106	CcSEcCtD
Vilazodone—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000262	0.00105	CcSEcCtD
Vilazodone—CYP2D6—brain—acquired immunodeficiency syndrome	0.000257	0.00965	CbGeAlD
Vilazodone—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000257	0.00103	CcSEcCtD
Vilazodone—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000252	0.00101	CcSEcCtD
Vilazodone—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000247	0.000992	CcSEcCtD
Vilazodone—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000236	0.000946	CcSEcCtD
